FAETH THERAPEUTICS INC
FTH · NASDAQ
Updated at 2026-10-14 08:52:42
- Today's High
- $23.53
- Today’s Low
- $21.34
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $26.00
- Previous Close
- $23.25
- Volume
- 309.83K
- Market Cap
- $600.79M
- P/E Ratio
- --
- EPS
- $-141.64
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1405 RESEARCH BOULEVARD, ROCKVILLE, MD, UNITED STATES, 20850
- Country
- US
- Listing Date
- 2021-02-04
- Fiscal Year End
- December
- Shares Outstanding
- 25.78M
- CIK
- 0001829802
- Website
- www.senseibio.com
Faeth Therapeutics, Inc. is a pioneering biotechnology company focused on transforming cancer treatment through its innovative approach to immunotherapy. Leveraging advanced protein engineering and proprietary technologies, Faeth aims to enhance the body's natural defenses to target and eliminate cancer cells effectively. The company's robust pipeline includes promising candidates that address significant unmet medical needs in oncology, positioning Faeth as a key player in the evolving landscape of cancer therapeutics. With a dedicated management team and strong scientific expertise, Faeth Therapeutics is poised to make substantial strides in improving patient outcomes in the fight against cancer.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
-$4.85M
Operating Expenses
2026-06-30
$18.38M
2026-03-31
$37.67M
2025-12-31
$4.95M
2025-09-30
$4.85M
Net Income
2026-06-30
-$16M
2026-03-31
-$170.23M
2025-12-31
-$4.71M
2025-09-30
-$4.56M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
94.18%
Earnings Per Share
2026-06-30
$-2.84
2026-03-31
$-131.45
2025-12-31
$-3.74
2025-09-30
$-3.62
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$15.98M
2026-03-31
-$170.2M
2025-12-31
-$4.68M
2025-09-30
-$4.52M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | -$4.85M |
| Operating Expenses | $18.38M | $37.67M | $4.95M | $4.85M |
| Net Income | -$16M | -$170.23M | -$4.71M | -$4.56M |
| Net Profit Margin | -- | -- | -- | 94.18% |
| Earnings Per Share | $-2.84 | $-131.45 | $-3.74 | $-3.62 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$15.98M | -$170.2M | -$4.68M | -$4.52M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.